<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">In certain situations, the antiviral medications oseltamivir or zanamivir can be used as an adjunct to vaccination for prevention of influenza. In a meta-analysis of prophylaxis trials, both medications demonstrated a significant reduction in the risk of symptomatic influenza in individuals and in households [
 <xref ref-type="bibr" rid="CR35">35</xref>]. However, due to concern for increasing viral resistance, the CDC does not recommend the routine use of chemoprophylaxis for prevention of influenza, but rather recommends judicious use for those with known exposure who are at high risk for influenza complications or for whom the influenza vaccine is contraindicated [
 <xref ref-type="bibr" rid="CR34">34</xref>].
</p>
